Structural role of disulfide bridges in the cyclic ADP-ribose related bifunctional ectoenzyme CD38  by Guida, Lucrezia et al.
FEBS 15787 FEBS Letters 368 (1995) 481484 
Structural role of disulfide bridges in the cyclic ADP-ribose related 
bifunctional ectoenzyme CD38 
Lucrezia Guida, Luisa Franco, Elena Zocchi, Antonio De Flora* 
Institute of Biochemistry, University of Genoa, and Advanced Biotechnology Center, Viale Benedetto XV/1, 16132 Genoa, Italy 
Received 19 May 1995; revised version received 13 June 1995 
Abstract Human CD38, a type II cell surface glycoprotein, is 
a bifunctional ectoenzyme catalyzing both ADP-ribosyl cyclase 
and cyclic ADP-ribose (cADPR) hydrolase reactions. It shares 
a high degree of sequence homology with the cyclase from Aplysia 
species and studies of site-directed mutagenesis have recently 
demonstrated the importance, but not elucidated the role, of sev- 
eral cysteine residues highly conserved between these proteins. 
N-Ethylmaleimide, iodoacetamide and thiol-oxidizing reagents 
failed to affect either the cyclase or the weaker hydrolase activity 
of the Aplysia californica protein. Likewise, these reagents did 
not impair the two activities of CD38 purified from human eryth- 
rocytes, fl-mercaptoethanol had no effect on the Aplysia enzyme 
activities, while it inactivated both the cyclase and the cADPR 
hydrolase of CD38 by inducing its extensive oligomerization. In 
intact erythrocytes the fl-mercaptoethanol-dependent zyme in- 
activation was completely prevented by prior cross-linking of the 
membrane proteins with glutaraldehyde. These data demonstrate 
that none of the cysteine residues plays any direct catalytic role 
in CD38 and Aplysia proteins, and that disulfide bridges are 
essential for maintaining the monomeric, catalytically active 
structure of CD38. 
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1. Introduction 
CD38 is a 46 kDa cell surface glycoprotein present on early 
and late differentiation stages of lymphocytes and on a number 
of other cells [1]. Several studies have highlighted two main 
features of CD38. First, it behaves as an orphan receptor, as 
shown by activation and differentiation programs triggered by 
'agonistic' monoclonal antibodies that mimic so far unidenti- 
fied physiologic ligand(s) [2]. A second property of CD38 is its 
nature of bifunctional ectoenzyme catalyzing both the conver- 
sion of NAD ÷ to nicotinamide and cyclic ADP-ribose 
(cADPR), through an ADP-ribosyl cyclase reaction, and the 
hydrolysis of cADPR to free ADP-ribose (ADPR) [3-7]. Grow- 
ing interest oward cADPR is justified by its nature of IP 3- 
independent Ca 2+ mobilizer in several cell types (see [8] for a 
review) and compartments [9]. 
The demonstration f CD38 as a bifunctional enzyme arose 
from its high degree of amino acid sequence identity [10] with 
ADP-ribosyl cyclase from Aplysia caliJbrnica [11] and Aplysia 
*Corresponding author. Fax (39) (10) 35-4415. 
Abbreviations: NGD ÷, nicotinamide guanine dinucleotide; GDPR, gua- 
nosine diphosphate ribose; cGDPR, cyclic guanosine diphosphate ri-
bose. 
kurodai [12]. Specifically, 10 cysteine residues are conserved 
between the Aplysia enzymes and human CD38. Two out of six 
additional cysteines (residues 119 and 201) found in the CD38 
sequence, but not in the Aplysia protein, were recently reported 
to be involved in the cADPR hydrolase reaction [13]. Thus, on 
the basis of elegant site-directed mutagenesis studies, Okamoto 
and coworkers [13] converted CD38 to a monofunctional en- 
zyme apparently devoid of cADPR hydrolase activity by re- 
placing cysteines 119 and 201. In addition, they reverted the 
monofunctional cyclase activity of Aplysia protein to a CD38- 
like bifunctional enzyme (i.e. cyclase/hydrolase), by restoring 
the two cysteines corresponding to residues 119 and 201 of 
CD38 [13]. 
Although these studies point to the importance of specific 
cysteine residues for CD38 catalysis, their redox state and pre- 
cise role remain controversial. The enzyme activity (measured 
as disappearance of 1,N6-etheno-NAD ÷)of CD38 from retinoic 
acid-differentiated HL-60 cells has been reported to be inhib- 
ited by dithiothreitol [4]. Moreover, extensive self-aggregation 
and inactivation of native erythrocyte CD38, both purified [14] 
and in situ within membranes [15], take place following expo- 
sure to fl-mercaptoethanol or to GSH. On the other hand, 
inhibition of the Aplysia kurodai ADP-ribosyl cyclase by dithio- 
threitol has been reported by Tohgo et al. [13], but not con- 
firmed by Inageda et al. [16]. These data, coupled with our 
preliminary observation that, despite the absence of cysteines 
119 and 201, the Aplysia californica enzyme does exhibit a weak 
cADPR hydrolase activity, suggested to re-investigate he role 
of cysteines/cystines using both the Aplysia protein and human 
CD38. Our results allow to exclude any direct involvement of 
cysteine residues in the catalytic mechanism of cyclase and 
hydrolase activities, while they demonstrate an essential role of 
disulfide bridges in maintaining the monomeric, catalytically 
active structure of CD38. 
2. Materials and methods 
2.1. Materials 
ADP-ribosyl cyclase, purified from Aplysia californica ovotestis as 
described previously [17], was a generous gift of Prof. H.C. Lee, Minne- 
apolis, MN. CD38 was purified from human erythrocyte membranes 
as described [5]. Anti-CD38 monoclonal ntibody IB4 [2] was kindly 
provided by Prof. F. Malavasi, Turin, Italy. Recombinant human 
CD38 [18] was provided by Dr. W.D. Branton, Minneapolis, MN. 
Blood samples were obtained from normal volunteers using heparin as 
anticoagulant. Leukocytes and platelets were removed with a leukocyte 
removal filter (Sepacell, Asahi Medical Co., Tokyo, Japan). All chem- 
icals were of the highest purity grade available from Sigma. 
2.2. Assay of cyclase and hydrolase activities of the Aplysia enzyme 
The purified enzyme (0.13 pg/ml) was incubated at 37°C in the 
presence of 10 mM Tris-HCl, pH 6.5, and 0.1 mM NAD + for 15 min 
(to assay cyclase activity) or 0.1 mM cADPR for up to 5 h (to estimate 
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hydrolase activity). At different times, aliquots were withdrawn, depro- 
teinized with TCA (5% final concentration), centrifuged and the xcess 
TCA removed with diethylether. The amounts of nucleotides produced 
were determined by HPLC analysis as described below. 
2.3. Assay of cyclase and hydrolase activities of human CD38 
Purified CD38 (0.1/tg/ml) was incubated for up to 4 h at 37°C in the 
presence of 10 mM Tris-HC1, pH 6.5, 0.05% Triton X-100 and 0.1 mM 
NGD + (for cyclase activity) or 0.1 mM cADPR (for hydrolase activity). 
Aliquots were withdrawn at different times, deproteinized asabove and 
subjected to HPLC analysis. 
2.4. HPLC analyses 
These were performed on a Hewlett-Packard HP 1090 instrument. 
A 5 m, 60 x 4.6 ram, ODS-Hypersil C~8 reverse phase (Hewlett-Pack- 
ard) column was used. Solvent A was 0.1 M KHzPO4 containing 5 mM 
tetra-n-butylammonium, pH 5.0; solvent B was solvent A containing 
30% (v/v) methanol. The solvent program was a linear gradient (at a 
flow rate of 0.4 ml/min) starting at 100% solvent A and increasing to 
100% solvent B in 30 min. The nucleotides were detected by a HP 1040 
A diode array spectrophotometric detector set at 260 nm. The elution 
times (in minutes) of standard nucleotides were: cGDPR 4.5, cADPR 
5.6, NGD + 8.0, NAD ÷ 12, GDPR 16.5, ADPR 23. 
2.5. SDS-PAGE 
Purified CD38 (10 ng) was subjected o SDS-PAGE and Western blot 
as in [15]. Saturation of 0.45/zm nitrocellulose membranes (Hybond- 
ECL, Amersham, Italy) with milk-powder, incubation with anti-CD38 
MoAb [2] and immunoenzymatic detection were performed following 
instructions of the Amersham ECL chemiluminescence assay kit. 
2.6. Incubation fintact erythrocytes with glutaraldehyde and 
fl-mer captoethanol 
Washed human erythrocytes, withdrawn as described above, were 
preliminarily incubated at a 10% hematocrit n 0.15 M NaC1, in the 
absence or presence of 0.15% (v/v) glutaraldehyde, for 15 min at 25 ° C. 
After two washings of the glutaraldehyde-pretreated samples with 10 
mM glycine in 0.15% M NaC1 and two further washings with 0.15 M 
NaC1, erythrocytes were incubated at 37°C for 5 or 30 min, respectively, 
at a 35% hematocrit, in 10 mM Tris, pH 6.5, containing 0.15 M NaC1, 
5 mM glucose (Buffer A) and 0.1 M fl-mercaptoethanol (omitted in the 
control suspensions). Erythrocytes were then washed 5 times with 0.15 
M NaC1 and submitted to assays of ADP-ribosyl cyclase and cADPR 
hydrolase activities, using 0.1 mM NGD ÷ and 0.1 mM cADPR, respec- 
tively, as substrates. The assay mixtures (35% hematocrit) contained 
Buffer A and 1 mM fl-mercaptoethanol and were incubated for 15 and 
30 rain at 37°C. Analyses of the various metabolites were performed 
by HPLC on TCA extracts of the supernatants, asdescribed above. 
3.  Resu l ts  
The ADP-ribosyl cyclase from Aplysia californica exhibits 
also a weak cADPR hydrolase activity, accounting for nearly 
1% of the cyclase, that could be detected by properly prolong- 
ing the time of incubation (not shown). 
We next addressed the question of whether any of the 10 
cysteine residues present in the Aplysia protein is directly in- 
volved in the catalytic mechanism of the cyclase/hydrolase reac- 
tions. As shown in Table 1, neither the thiol-modifying reagents 
NEM and iodoacetamide nor thiol-oxidizing compounds like 
H202 and CuZ+-o-phenanthroline, affected ei her catalytic ac- 
tivity detectably, f l-Mercaptoethanol (fl-ME), as high as 100 
mM, was ineffective, thus ruling out any important role of 
disulfide bonds in maintaining an active conformation of the 
invertebrate protein. 
Since human CD38 has six additional cysteine residues which 
are missing or otherwise replaced in the Aplysia protein [10,11], 
the same experiments designed to elucidate the role of sulfhy- 
dryl vs. disulfide groups were performed also with CD38 puri- 
fled from human erythrocyte membranes. However, its c6m- 
paratively higher cADPR hydrolase than cyclase activity [5] 
suggested to use NGD ÷ as substrate of the cyclase [18,19]. In 
fact, NAD ÷ is eventually converted by CD38 to ADPR through 
cADPR as a transient intermediate, thereby reproducing an 
'NADase'  reaction that leads to underestimating the intrinsic 
cyclase activity. NGD ÷, on the contrary, proved in preliminary 
experiments o be converted to cGDPR to a much higher extent 
than to GDPR (78 + 2% cGDPR vs. 12 + 2% GDPR formed, 
respectively), this indicating a much lower susceptibility of 
cGDPR than of cADPR to hydrolysis by native CD38. This 
finding, which is quite similar to those previously reported with 
a recombinant soluble form of human CD38 [18], allowed to 
measure the cyclization reaction without appreciable interfer- 
ences by the hydrolase activity. Thus, the intrinsic cyclase activ- 
ity of purified CD38 was estimated to be 2.8 tool cGDPR/min/ 
mg and the ratio of cyclase to hydrolase activity was accord- 
ingly much higher (around 1) than previously estimated with 
NAD + as substrate, i.e. 1/10 [5]. 
As shown in Table 1, none of the thiol-modifying or thiol- 
oxidizing reagents affected either the cyclase or the hydrolase 
activity of CD38. On the other hand, unlike what was observed 
with the Aplysia protein, addition of fl-mercaptoethanol (ti- 
ME) resulted in a concentration-dependent loss of both enzyme 
activities. This is in agreement with our previous results on the 
purified and on the membrane-bound human CD38 [14,15] and 
also with the reported inhibition of the NADase activity of 
CD38 by DTT [16], that is in fact the time-dependent loss of 
the combined cyclase and hydrolase activities of this glycopro- 
tein. That inactivation by f l -ME was actually accompanied by 
self-aggregation f CD38 was shown by disappearance of the 
monomeric 46 kDa immunoreactive protein band (Fig. 1). 
When intact native erythrocytes, that possess both cyclase and 
cADPR hydrolase ectoenzyme activities [20], were incubated 
with 100 mM fl-ME, a progressive inactivation was observed 
(Table 2). Preliminary treatment of intact erythrocytes with 
glutaraldehyde at concentrations not impairing CD38 enzyme 
Table 1 
Effect of thiol-modifying an thiol-oxidizing reagents on ADP-ribosyl 
cyclase and cADPR hydrolase activities of the Aplysia californica pro- 
tein and human CD38 
Activities (%) 
Aplys& protein Human CD38 
Reagent (mM) Cyclase Hydrolase Cyclase Hydrolase 
- 100 100 100 100 
NEM (1) 99 99 98 99 
Iodoacetamide (1) 98 97 97 97 
H202 (10) 97 96 99 98 
CuZ+-o-phenanthroline 102 100 101 100 
(0.05) 
fl-mercaptoethanol (10) 100 99 81 83 
fl-mercaptoethanol (100) 99 98 20 27 
The Aplysia protein (0.13 ,ug/ml) was pre-incubated 30 min at 37°C in 
10 mM Tris-HC1, pH 6.5, containing the compounds indicated at the 
concentrations shown between parentheses. CD38 purified from 
human erythrocytes membranes [5] was pre-incubated at0.1/lg/ml in 
the same conditions, but with the addition of 0.05% Triton X-100. After 
pre-incubation, the mixture were assayed for cyclase and hydrolyse 
activities as described in section 2. Results are expressed as percentage 
of enzyme activities detected without any thiol reagent. Results of a 
representative experiment are shown, out of five ones in which variabil- 
ity never exceeded 7%. 
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Fig. 1. SDS-PAGE and immunoblotting of human CD38 incubated 
with fl-mercaptoethanol. Purified CD38 (0.1/tg/ml) was incubated for 
30 rain at 37°C without (lane A) and with 10 mM (lane B) and 100 mM 
(lane C) fl-mercaptoethanol, in the same conditions as in the legend to 
Table 1. The samples were then submitted to SDS-PAGE followed by 
Western blotting and immunoassay, asdescribed in section 2. 
activities (e.g. 0.15% (v/v), as shown in Table 2), conferred 
complete stability of cyclase and hydrolase activities upon fur- 
ther exposure of the cells to otherwise inactivating 100 mM 
fl-ME (Table 2). These data indicate that the process of enzyme 
inactivation by E-ME requires two sequential steps, the first 
being disulfide bond reduction, followed by oligomerization of
active monomeric CD38 to yield low activity aggregates. 
4. Discussion 
CD38 and CD38-related proteins, previously classified as 
NAD+-glycohydrolases [8,21,22], convert NAD + to ADPR in 
two separate but mechanistically related steps, i.e. cyclization 
and hydrolysis. Several evidences indicate that an ADP-ribosyl- 
ated enzyme intermediate is formed during catalysis by CD38, 
thereby leading to cADPR or ADPR formation depending on 
absence or availability of water, respectively, at the active site 
[16,18,21,23,24]. Since NAD+-dependent ADP-ribosylation of 
proteins can occur on a number of amino acid residues, includ- 
ing cysteines [25], the presence of many cysteine residues in 
CD38 and in Aplysia cyclase might suggest heir catalytic in- 
volvement through transient ADP-ribosylation. This possibil- 
ity, however, has been ruled out (Table 1) and ADP-ribosyl 
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amino acid acceptors other than cysteines eem to be involved 
in both proteins. 
Detection of a weak cADPR hydrolase activity in the Aplysia 
cyclase gives further support to the two-step mechanism of 
catalysis, although this protein is mostly dedicated to cycliza- 
tion. Moreover, it indicates that residues 95 and 176 in the 
Aplysia protein (lysine and glutamic acid, respectively, as com- 
pared to two cysteine residues in the CD38 sequence), although 
being important in affecting the balance between cyclase and 
hydrolase activities, as previously shown by site-directed mut- 
agenesis tudies [13], do not take part directly in the catalysis. 
On the other hand, susceptibility of cyclase and hydrolase 
activities of human CD38 to fl-mercaptoethanol suggests that 
disulfide bond(s) is(are) somehow required to stabilize a cata- 
lytically active conformation. This is apparently a peculiar fea- 
ture of the 46 kDa monomer since fl-ME results in its disap- 
pearance ([14,15]; Fig. 1) and, concomitantly, in the loss of both 
enzyme activities (Table 1). Monomer disappearance and en- 
zyme inactivation may not be strictly comparable from a quan- 
titative standpoint in vitro (compare Table 1 and Fig. 1 at 
10-100 mM fl-ME), as a result of various experimental condi- 
tions like detergent and protein concentration and variable 
accessibility of substrate(s) to the active site in the aggregates 
(not shown). 
Results on intact native erythrocytes exposed to fl-ME are 
indicative of a condition of partially restricted in situ mobility 
of CD38 within the membrane, that leads to a delayed inactiva- 
tion of both cyclase and hydrolase (Table 2), as previously 
observed also on erythrocyte membranes incubated with GSH 
[15]. Additional restriction of CD38 lateral diffusion by prior 
cross-linking of membrane proteins on intact erythrocytes with 
glutaraldehyde abolishes completely the susceptibility of both 
ectoenzyme activities to reductive inactivation (Table 2). All 
these data point to a two-step inactivation (i.e. reduction fol- 
lowed by oligomerization) rather than to direct inhibition by 
fl-ME, and suggest accordingly an important conformational 
role, rather than direct catalytic involvement, of disulfide 
bond(s) located in the ectocellular region of CD38. Such local- 
ization is also supported by susceptibility to fl-ME-induced 
self-aggregation f a recombinant soluble form of CD38 [18], 
corresponding to its ectocellular domain (not shown). 
On the basis of the present experiments, reductive op ning 
of disulfide bridge(s) by fl-ME seems to trigger a drastic hange 
in the conformation of CD38 monomers followed by their 
stable and apparently non-ordered oligomerization [14]. Identi- 
fication of the bonds and/or domains responsible for such 
Table 2 
Effect of glutaraldehyde tr atment ofintact erythrocytes on the fl-mercaptoethanol-induced inactivation of ADP-ribosyl cylase and cADPR hydrolase 
ectoenzyme activities 
Pre-incubated fl-mercaptoethanol Cyclase Hydrolase 
(0.1 M, minutes of (pmol cGDPR/min/mgHb) (pmol ADPR/min/mgHb) 
exposure) 
- - 5.53 (100%) 6.79 (100%) 
Glutaraldehyde - 5.43 (98%) 6.60 (97%) 
- 5 4.15 (75%) 4.76 (70%) 
30 1.93 (35%) 2.51 (37%) 
Glutaraldehyde 5 5.49 (100%) 6.75 (99%) 
Glutaraldehyde 30 5.51 (100%) 6.80 (100%) 
Details of incubation are provided in section 2. Results of a representative experiments ar  shown, out of five different ones in which variability never 
exceeded 11%. 
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CD38 self-aggregation will be the subject of further work. How- 
ever, four leucine zipper-like sequences [26] that occur in 
the ectocellular portion of CD38 (residues 124-145, 150-164, 
208-229 and 271-285, respectively), may be involved in the 
fl-ME-initiated process of oligomerization. The behaviour of 
Aplysia protein, which unlike CD38, is completely refractory 
to inactivation by fl-ME and where only one out of the four 
mentioned hydrophobic motifs (residues 183-204) is partially 
conserved [11], is consistent with this hypothesis. 
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